LCTXHealthcareSmall-Cap
Lineage Cell Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Lineage Cell Therapeutics, Inc. (LCTX), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are LCTX insiders buying or selling?
Lineage Cell Therapeutics, Inc. insiders reported 21 open-market buys ($14.7M) and 5 sells ($2.7M) across 26 Form 4 filings — a net buying position of $12.0M.
Source: SEC EDGAR Form 4
Key Statistics (as of Mar 12, 2026)
Total Form 4 filings
26
SEC EDGAR
Insider filers
14
Insider buys (21)
$14.7M
Insider sells (5)
$2.7M
Insider sentiment
Net buyingNet insider flow of $12.0M in net buying.
Recent LCTX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Brian M Culley | President and CEO | Purchase | 15.0K | $1.63 | $24.4K |
| Jan 29, 2025 | Neal C Bradsher | Director, 10% Owner | Purchase | 7.9M | $0.76 | $6.0M |
| Nov 26, 2024 | Jill Ann Howe | Chief Financial Officer | Purchase | 15.0K | $0.59 | $8.8K |
| Nov 26, 2024 | George A. Samuel III | General Counsel | Purchase | 15.0K | $0.60 | $9.0K |
| Nov 25, 2024 | Michael H. Mulroy | Director | Purchase | 40.0K | $0.57 | $22.6K |
| Nov 22, 2024 | Brian M Culley | President and CEO | Purchase | 40.0K | $0.60 | $24.0K |
| Aug 19, 2024 | Jill Ann Howe | Chief Financial Officer | Purchase | 10.5K | $0.89 | $9.3K |
| May 28, 2024 | Brian M Culley | President and CEO | Purchase | 10.0K | $1.05 | $10.5K |
| Feb 9, 2024 | Don M Bailey | Director | Purchase | 96.2K | $1.04 | $100.0K |
| Feb 8, 2024 | Neal C Bradsher | Director, 10% Owner | Purchase | 6.7M | $1.04 | $7.0M |
| Jan 3, 2024 | Anula Jayasuriya | Director | Purchase | 10.0K | $1.09 | $10.9K |
| Apr 4, 2022 | Brian M Culley | President and CEO | Purchase | 6.4K | $1.53 | $9.8K |
| Mar 29, 2022 | Dipti Amin | Director | Purchase | 35.0K | $1.63 | $57.0K |
| Mar 28, 2022 | Brian M Culley | President and CEO | Purchase | 5.3K | $1.38 | $7.2K |
| Mar 25, 2022 | Neal C Bradsher | Director, 10% Owner | Purchase | 930.1K | $1.42 | $1.3M |
| Mar 25, 2022 | Michael H. Mulroy | Director | Purchase | 7.0K | $1.40 | $9.8K |
| Dec 30, 2021 | Gary S. Hogge | SVP,Clinical & Medical Affairs | Sale | 539.3K | $2.45 | $1.3M |
| Jun 30, 2021 | Deborah J Andrews | Director | Sale | 19.1K | $2.93 | $56.1K |
| Jun 30, 2021 | Angus C. Russell | Director | Sale | 4.7K | $2.97 | $14.0K |
| Jun 30, 2021 | Brian M Culley | President and CEO | Sale | 450.0K | $2.87 | $1.3M |
| Apr 2, 2021 | Alexandra Hernandez | Sr Director Finance/Controller | Sale | 6.0K | $2.23 | $13.4K |
| Aug 15, 2019 | Neal C Bradsher | Director, 10% Owner | Purchase | 24.6K | $0.98 | $24.0K |
| Aug 15, 2019 | Chase C. Leavitt | General Counsel/Secretary | Purchase | 5.0K | $1.02 | $5.1K |
| Aug 15, 2019 | Brandi Roberts | CFO & SVP, Finance | Purchase | 5.0K | $1.01 | $5.0K |
| Aug 15, 2019 | Brian M Culley | President and CEO | Purchase | 10.0K | $1.01 | $10.1K |
Showing the 25 most recent of 26 Form 4 filings for Lineage Cell Therapeutics, Inc..
Most active LCTX insiders
- Brian M Culley7 filings
- Neal C Bradsher4 filings
- Deborah J Andrews2 filings
- Jill Ann Howe2 filings
- Michael H. Mulroy2 filings
Ask anything about LCTX insider activity
Use Trabud's AI agent to query Lineage Cell Therapeutics, Inc.'s Form 4 history in plain English — "Show me LCTX CEO purchases this year" or compare it against any other ticker.
Open the AI agentLCTX insider trading FAQ
Are Lineage Cell Therapeutics, Inc. insiders buying or selling?
Across 26 SEC Form 4 filings, Lineage Cell Therapeutics, Inc. (LCTX) insiders reported 21 open-market purchases totaling $14.7M and 5 sales totaling $2.7M. That is a net buying position of $12.0M.
How many insiders trade LCTX stock?
14 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Lineage Cell Therapeutics, Inc.. The most recent filing was accepted on Mar 12, 2026.
Where does Trabud get LCTX insider trading data?
All LCTX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.